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Abstract: 
Atherosclerosis is a chronic arterial disease responsible for the majority of vascular related 
deaths throughout the world. Immune cells and inflammation in conjunction with 
hyperlipidemia, play a key role in atherosclerosis development. Regarding the low efficacy of 
synthetic drugs and also the associated negative side effects which can adversely influence 
health-related quality of life, looking for natural, affordable and non-toxic substances appears 
to be necessary. Plant-derived natural products play a critical role in prevention and treatment 
of atherosclerosis. In this review, we aimed to outline the most important medicinal herbs 
effective on atherosclerosis through an impact on the immune system. 
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 Introduction: 
According to WHO estimates, cardiovascular disease (CVD)-related events such as 
myocardial infarction (MI) and stroke are responsible for one-third of deaths worldwide (1, 
2). Due to the increase in obesity and diabetes, CVD is expected to rise to roughly 44% by 
2030 so inflicting a great deal of pressure on healthcare services (3, 4). 
Atherosclerosis, as the leading cause of CVD, is a chronic inflammatory disorder of the 
vasculature (5) that is affected by genetic susceptibility and also different lifestyle factors 
including age, gender, stress, smoking and dietary habits (6, 7). However, in spite of lifestyle 
modifications and the development of new pharmacological approaches for reducing plasma 
concentrations of total cholesterol, CVD remains a predominant cause of mortality 
throughout the world (8, 9). 
Not only as a lipid accumulation disorder, but also as a chronic inflammatory process of 
arterial walls, atherosclerosis is induced by factors including an interaction of lipid 
metabolism imbalance, abnormal immune response and genetic alterations (10-12). In this 
regard, components of both innate and adoptive immune systems participate in 
atherosclerosis pathology (12, 13). Briefly, LDL-cholesterol deposits and accumulates in the 
arterial wall and then LDL is oxidized (OxLDL). It has been proposed that the formation of 
OxLDL is a critical incident that exacerbates inflammation in the arterial wall. Due to 
overexpression of adhesion molecules, different types of leukocyte and also monocytes 
migrate into the vascular wall and produce chemokines and pro-inflammatory cytokines. The 
uptake of OxLDL is performed by monocyte-derived macrophages through scavenger 
receptors transforming the cells into lipid-laden foam cells (13, 14). The differentiation into 
lipid-laden foam cells is crucial in the development of atherosclerosis (15). 
The first visible lesion in the development of atherosclerosis is a fatty streak which contains 
lipids and various immune cells consisting of T lymphocytes, dendritic cells, and 
macrophages. Progressed atherosclerotic lesions involve migrated smooth muscle cells 
(SMCs), debris, apoptotic cells, and extracellular matrix comprising collagen and 
proteoglycans (13). It is thought that B lymphocytes and their secreted immunoglobulins, 
including IgG and IgM, are associated with atherogenesis. Unstable atherosclerotic plaques 
may suddenly break off and give rise to a life-threatening coronary thrombosis. Substantial 
features of indolent plaque include infiltration of many inflammatory cells, a large lipid core, 
and a thin fibrous cap (16, 17). 
Pro-inflammatory cytokines like interleukin 1 and tumor necrosis factor regulate the 
expression of adhesion molecules involved in early and late stages of atherogenesis. IL-1 and 
TNF can stimulate the production of growth factors, including fibroblast growth factors 
(FGF) and platelet derived growth factor (PDGF). These growth factors attract smooth-
muscle cells into the tunica intima resulting in inflammation. However, other cytokines and 
growth factors may be important in developing a more advanced form of atherosclerosis with 
a decreased susceptibility of plaque to rupture. For example, interstitial collagen production is 
stimulated by transforming growth factor-b (TGF-b) while it is neutralized by interferon-g 
(IFN-g) (18, 19). 
Altogether, prevention of atherosclerosis might be achieved by intervening at each step or the 
inflammatory-associated factors involved in the atherogenesis process (14). 
Nevertheless, regarding the low efficacy of synthetic drugs and also their associated adverse 
effects including dry mouth, emotional distress, vertigo and stomach disturbances which can 
adversely affect health-related quality of life, looking for natural, affordable and non-toxic 
substances appears to be necessary. Currently, plants are widely used in traditional medicine 
to treat a broad spectrum of illnesses and approximately 80% of the emerging world 
population depends upon traditional medicine for primary health care (20). In this review, we 
aimed to outline the most important medicinal herbs effective on atherosclerosis through an 
impact on the immune system. 
 
Medicinal Plants and Atherogenesis 
 
Targeted intervention strategies, including anti-inflammatory and immunomodulatory 
approaches or lipid metabolism modifier-based procedures have been employed to control 
atherosclerosis (21, 22). Traditional medicine, which is profoundly ingrained in history, has 
been widely used to prevent and treat a variety of diseases including atherosclerosis. 
Medicinal herbs are supposed to suppress immune responses and any consequent 
inflammation. Having knowledge of medicinal plants employed in atherosclerosis 
management is very helpful to determine the possible use of these herbs in cytokine or lipid 
metabolism-based therapies. In the following discourse, the potential clinical predictive value 
of some medicinal herbs in reducing proinflammatory cytokine expression or modifying lipid 
metabolism in the management of the progression and complications of atherosclerosis will 
be explained. 
Turmeric 
 Turmeric (Curcuma longa) or “Indian saffron” is a spice that has also been used in some 
medicinal preparations and as a cosmetic for many years in Southeast Asian countries (23). 
One of the most well-known plant-based natural compounds, called Curcumin, is extracted 
from the rhizome of the Turmeric plant. Curcumin is a hydrophobic, low molecular weight 
polyphenol and also a major active component in turmeric. It has been shown to be effective 
in the treatment of age-associated diseases like atherosclerosis by exerting anti-
inflammatory, anti-oxidative, and anti-atherosclerotic effects (24). Studies have indicated 
that curcumin significantly represses MCP-1 production and increases cholesterol efflux 
through inhibition of JNK pathways and it has been concluded that curcumin protects the 
vascular system against developing atherosclerotic lesions (25). 
Cassia occidentalis  
Different parts of the annual herb Cassia occidentalis Linn. (Caesalpiniaceae) have a variety 
of medicinal impacts including anti-inflammatory, antihepatotoxic (26), antibacterial (27), 
antiplasmodial (28) and antidiabetic (29) properties. A leaf aqueous extract of this herb has 
been used for the treatment of cardiovascular diseases in African traditional medicine. 
According to studies, treating animal models with a leaf aqueous extract of Cassia 
occidentalis significantly increased the faecal excretion of cholesterol by transformation of 
cholesterol into biliary acids in rats subjected to a feeding regime high in cholesterol. 
Furthermore, by increasing LCAT activity, aqueous extract of Cassia occidentalis enriched 
the HDL-C out of cholesterol esters. Taken together, studies have provided evidence of 
involving the aqueous extract of C. occidentalis in lipid metabolism, even though safety has 
yet to be explored (28). 
Cornelian cherry  
Cornus mas L. (Cornelian cherry) is a flowering plant in the dogwood family. Due to its high 
antioxidant and anti-inflammatory properties, Cornelian cherry is considered a medicinal 
herb and applied in therapeutic approaches against a variety of conditions including 
inflammatory bowel disease, fever, kidney stones, urinary tract infections as well as bleeding. 
Moreover, several studies have demonstrated that Cornus mas L. has a protective role against 
atherosclerosis and give rises to a reduction of fat accumulation in the liver (30).   
Humulus japonicas  
 Humulus japonicas (HJ) is a decorative plant in the Cannabaceae family and is a native plant 
in temperate parts of Asia and the tropical area of Vietnam. According to a study conducted 
in 2016 by Lim et al, Humulus japonicas significantly prevented atherogenesis by repressing 
inflammation and the development of atherosclerotic lesions in vitro and in animal models, 
respectively. Humulus japonicas therefore, appears to be effective against the development of 
atherosclerosis, so it may have a potential therapeutic application in atherosclerosis treatment 
(9). 
Artemisia judaica L. 
Artemisia judaica L. is a medicinal herb which is specifically found in the southern desert of 
Jordan near to the Jordan-Saudi Arabia borders and in Wadi Araba in Southern Badia. A 
Study by Abu-Darwish et al., in 2016, revealed that safe concentrations of Artemisia judaica 
essential oil effectively suppress NO production evoked by lipopolysaccharide in 
macrophages, emphasizing the possible anti-inflammatory properties of Artemisia judaica 
(31). 
Salvia miltiorrhiza  
Salvia miltiorrhiza var. alba is a perennial plant in the genus Salvia. This herb is highly 
valued in traditional Chinese medicine. It has been used for many years in traditional Chinese 
medicine to treat cardiovascular diseases associated with inflammation including 
atherosclerosis. Ma et al., (2016) demonstrated that the root extract of Salvia miltiorrhiza 
effectively suppressed the expression of inflammatory factors including TNF-α, IL-1β, and 
IL-8 proposing a potential application of this herb in diseases like atherosclerosis due to its 
anti-inflammatory properties (32). 
Prosopis farcta  
Syrian mesquite (Prosopis farcta) is a species of the genus Prosopis and native to Asia, 
ranging from India to Iran. In herbal medicine, Prosopis farcta root is a suggested treatment 
for cardiovascular diseases. Saidi et al., (2016) investigated the efficacy of an aqueous extract 
of Prosopis farcta root on the development of experimental atherosclerosis in rabbits. 
According to their findings, serum lipid parameters including total cholesterol, HDL, TG, 
LDL, and VLDL levels were substantially increased in hypercholesterolemic animals. 
However, according to histopathological results, atherosclerotic plaque size was mimimally 
influenced. This outcome may reflect a decline of chest pain or the advantageous impacts of 
this plant root extract on cardiovascular health (33).  
Persimmon (Diospyros kaki L.)  
For many years, Persimmon leaves have been used to treat disorders like ischemic stroke, 
internal hemorrhage and atherosclerosis in traditional Chinese medicine. Xie et al., in a 
review on traditional uses of persimmon leaves published in 2015, declared that it could 
potentially be used as a therapeutic agent in cardiovascular disease treatment and prevention 
including atherosclerosis owing to its immunomodulatory and anti-inflammatory properties. 
However they proposed more investigation on the safety to use it as a natural drug in 
medicinal practices (34). 
Andrographis paniculata 
As an annual plant in the Acanthaceae family, Andrographis paniculata is widely found in 
Southern and Southeastern Asia. For many years, its main bioactive component called 
Andrographolide (AND) has been used in herbal remedies. According to different studies 
AND exerts its antiatherogenic properties by reducing VCAM-1 and ICAM-1 as two cell 
adhesion molecules which play a key role in migration of vascular smooth muscle cells 
(SMCs) (35). 
Plectranthus zeylanicus Benth 
Plectranthus zeylanicus Benth is a perennial herb cultivated in Sri Lanka and South India. 
People native to these two countries use it as a remedy to treat inflammatory diseases such as 
asthma and atherosclerosis. Napagoda et al., (2014) in their study revealed that Plectranthus 
zeylanicus Benth inhibited 5-lipoxygenase (5-LO). 5-LO  has a key role in initiating the 
biosynthesis of pro-inflammatory leukotrienes, thus emphasizing the anti-inflammatory 
impact of this remedy in managing inflammatory associated diseases including 
atherosclerosis (36).  
Prunella vulgaris 
As a perennial herbaceous plant, Prunella vulgaris is widely distributed throughout the 
world. This herb belongs to the prunella genus, and for many years it has been used in herbal 
medicine to treat inflammatory diseases. A study published in 2013 indicated that Prunella 
vulgaris can reduce the expression of adhesion molecules including intercellular adhesion 
molecule-1, vascular cell adhesion molecule-1, E-selectin and also the activation of N1F-kB. 
Molecular analysis revealed that Prunella vulgaris exerts its anti-inflammatory effects by 
inhibiting the p38 MAPK/ERK signaling pathway (37). 
Phyllostachys edulis (Bamboo) 
For centuries, Bamboo leaves have been used as a food or a natural remedy in Asian 
countries like Japan and Korea. Owing to its anti-inflammatory and anti-oxidant activity, 
Bamboo leaves may be beneficial in treating cardiovascular diseases including 
atherosclerosis. In vitro investigation of Bamboo leaf extract effects on human umbilical vein 
endothelial cells (HUVECs) has shown that it is able to inhibit monocyte adhesion and 
vascular cell adhesion molecule-1 expression, reduce oxygen species generation and inhibit 
interleukin-6 secretion from lipopolysaccharide-stimulated monocytes (38). 
Panax notoginseng saponins  
Panax notoginseng saponins, also known as Chinese ginseng in English, has been used for 
many years as a natural remedy for cardiovascular diseases in Asian countries including 
China, Korea and Japan. Studying Panax notoginseng saponins (PNS) effects on 
atherosclerosis in rats has indicated that PNS upregulates liver X receptor alpha (LXRα) 
expression and consequent ABCA1 and ABCG1 overexpression and it also inhibits NF-κB 
DNA binding activity. LXRα as a receptor, regulates macrophage function which is involved 
in lipid metabolism and inflammation (39). 
PNS not only decreases lipids, serum Ox-LDL level as well as CD40 and MMP-9 
expressions in apoE (−/−) mice (40), but also lessens the size of atherosclerotic plaques, 
enhances endothelialization (41) and suppresses the formation of foam cells (42).  
Furthermore, a Ginsenoside derivative known as Ginsenoside Rd  blocks voltage dependent 
Ca2+ channels and markedly decreases  the size of atherosclerotic plaques and Ox-LDL in the 
apoE (−/−) rats. Moreover, the formation of foam cells is suppressed by Ginsenoside Rd in 
vitro (42). Conclusively, with regard to the anti-inflammatory effects of PNS and also its role 
in lipid metabolism regulation, this natural remedy might be introduced as a potential 
therapeutic agent in atherosclerosis treatment. 
 
 
Astragalus mongholicus Bunge 
In traditional Chinese medicine, Astragalus mongholicus Bunge has been used for hundreds 
of years. Studies using animal models and clinical trials have demonstrated that this 
medicinal herb may be beneficial in atherosclerosis. Thus, an extract of Astragalus 
mongholicus Bunge lowered total cholesterol and triglyceride in the blood and also the levels 
of LDL cholesterol and apolipoprotein B. Moreover, Astragalus mongholicus Bunge extract 
reduced fatty streaks and the sclerosing index (43). Total flavonoids of Astragalus (TFA) as 
the major active ingredient in Astragalus mongholicus Bunge is thought to possess the main 
antioxidant activity of this extract in managing atherosclerosis (44). 
Perilla frutescens 
Perilla frutescens is a leafy vegetable cultivated widely in some Asian countries, including 
Japan, and China. This herb exists in two varieties: red and green. Exhibiting its antioxidant 
effect, Perilla frutescens reduces LDL oxidizability. As mentioned earlier, oxidative 
modification of LDL plays a crucial role in the pathogenesis of atherosclerosis and anti-
oxidant activity can be induced by polyphenol compounds contained in the leaves of Perilla 
frutescens. Oral consumption of the red variety of Perilla frutescens results in a longer 
oxidation lag time and also a significant reduction in lipid peroxide formation as well as the 
electrophoretic mobility of LDL. Taken together, Perilla frutescens consumption can be 
beneficial for medicinal purposes against the development of atherosclerosis (45). 
Dachaihutang  
A study performed in 2009 by et al., in rabbits revealed that early treatment of arterial lesions 
led to a reduction of atherosclerosis size. Dachaihutang resulted in the regression of lesions 
and also prevented atherosclerosis development by upregulation of carnitine patmitoyl 
transferase-1(CPT-1) expression in vascular smooth muscle layers. The treated animal group 
also displayed a reduction in total cholesterol, triglyceride and LDL serum levels (46).  
 Cortex moutan  
Cortex Moutan (CM, root bark of Paeonia suffruticosa Andrews) is widely used in traditional 
Chinese medicine due to its analgesic, antipyretic, and anti-inflammatory properties and also 
its ability to prevent thromboembolic diseases. Paeonol is one of the major active ingredients 
in Cortex Moutan which is thought to contribute to the anti-atherosclerotic effect of this 
remedy. Cortex Moutan exerts its anti-atherosclerotic activity by reducing atherosclerosis 
plaque formation and also by suppressing TNF- alpha, IL-1 beta, and CRP and the 
translocation of NF- kappaB to the nucleus (47). 
Ginkgo biloba 
Ginkgo biloba is largely cultivated and is native to China. To assess the effect of this popular 
traditional medicine, Pierre et al., (2008) conducted an in vitro study using an extract from 
Ginkgo biloba with well-known antioxidant properties. Ginkgo biloba extract Egb-761, a 
standardized formulation of Gingko leaf extract, protected adhesive properties so preventing 
endothelial dysfunction as a key event in atherosclerosis development. EGb-761 mediates an 
inhibition of increased lipoperoxide level by limiting the reduction of Na+/K+-ATPase 






Lycopus lucidus is widely used in oriental traditional medicine. Pretreatment of exposed- to- 
high- glucose primary cultured human umbilical vein endothelial cells (HUVEC) with 
aqueous extract of the leaves of L. lucidus Turcz. (ALT) demonstrated that CAMs expression 
was significantly attenuated and the enhanced cell adhesion between monocyte and HUVEC 
was blocked. In addition, translocation and promoter transcriptional activity of NF-kappaB 
was suppressed. All of these consequences can contribute to prevention and treatment of 
atherosclerosis as a major complication of diabetes mellitus (49). 
Zingiber Officinale Rosc (ginger) 
Zingiber officinale Rosc is widely used as a spice and also in Chinese traditional medicine 
and other traditional medicinal systems as a herbal medication. Surveys have indicated that 
ginger in atherosclerosis exerts its effect by decreasing plasma lipid levels and the size of 
atherosclerotic lesions and these properties are due to antioxidative activity. This plant could 
have an inhibitory or scavenging effect on radicals by increasing GSH-Px and reducing LPO 
(50).  
Garlic 
Garlic has been widely used to prevent and treat cardiovascular diseases for many years. S-
allyl cysteine (SAC) is the main constituent of garlic that inhibits NO production by 
suppression of iNOS mRNA and protein expression. Moreover, by suppressing the 
production of hydroxyl radicals, garlic extract demonstrates antioxidant activity. These 
properties make garlic an effective natural medication against inflammatory based diseases 
including atherosclerosis (51). 
 
Quercus infectoria 
Quercus infectoria is native to southern Europe and the Middle East. This plant has high 
antioxidant activity by inhibiting Ox-LDL production thereby preventing atherosclerosis 
development. 
Furthermore, Quercus infectoria extract reduces the level of total cholesterol, triglyceride and 
LDL in plasma, emphasizing its contribution in atherosclerosis prevention and treatment (52).  
Conclusion:  
Although, using synthetic compounds to treat and prevent diseases is attractive, these types of 
medications can cause side effects. According to preclinical and clinical studies, natural herbs 
represent potential therapeutic agents in the prevention and treatment of atherosclerosis. 
Atherosclerosis is the crosstalk of lipid metabolism and inflammation. Medicinal plants may 
have various properties extended from antioxidant and antihyperlipidemic properties to anti-
endothelial dysfunction activity. These features introduce them as potential medications 
against atherosclerosis. However, sometimes the exact underlying mechanisms have not been 
precisely determined or understood. These herbs bear promising therapeutic potential to 
develop safer and less expensive medications to prevent and treat various conditions 
including atherosclerosis. However, their safety needs to be explored in more detail. 
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